As shown in Figure 6B, B7-H3, TIM3, PD-1 and PD-L1 have a significantly positive relationship with CNN3, which indicates that CNN3 might be an immunotherapeutic target in glioma. The gene discussed is CD276; the disease is central nervous system cancer.